An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999-2016: An observational study


Autoři: Steven J. Forrester aff001;  Elena V. Dolmatova aff001;  Kathy K. Griendling aff001
Působiště autorů: Department of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, United States of America aff001
Vyšlo v časopise: PLoS ONE 15(1)
Kategorie: Research Article
doi: 10.1371/journal.pone.0225207

Souhrn

Background

Hypertension-related mortality has been increasing in recent years; however, limited information exists concerning rate, temporal, secular, and geographic trends in the United States.

Methods and results

Using CDC death certificate data spanning 1999–2016, we sought to delineate trends in deaths attributable to an underlying cause of hypertension using joinpoint regression and proportion testing. From 1999–2016, the hypertension-related mortality rate increased by 36.4% with an average annual percent change (AAPC) of 1.8% for individuals ≥ 35 years of age. Interestingly, there was a notable acceleration in the AAPC of hypertension mortality between 2011 and 2016 (2.7% per year). This increase was due to a significant uptick in mortality for individuals ≥ 55 years of age with the greatest AAPC occurring in individuals 55–64 (4.5%) and 65–74 (5.1%) years of age. Increased mortality and AAPC were pervasive throughout sex, ethnicity, and White and American Indian or Alaska Native race, but not Black or African American race. From 2011–2016, there were significant increases in AAPC for hypertension-related mortality with contributing causes of atrial fibrillation, heart failure, diabetes, obesity, and vascular dementia. Elevated mortality was observed for conditions with a contributing cause of hypertension that included chronic obstructive pulmonary disease, diabetes, Alzheimer’s, Parkinson’s, and all types of falls. Geographically, increases in AAPCs and mortality rates were observed for 25/51 States between 2011 and 2016.

Conclusions

Our results indicate hypertension-related mortality may have accelerated since 2011 for middle-aged and older Americans, which may create new challenges in care and healthcare planning.

Klíčová slova:

African American people – Age groups – Death rates – Diabetes mellitus – Hypertension – Chronic obstructive pulmonary disease – Primary hypertension – Secondary hypertension


Zdroje

1. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137(12):e67–e492. doi: 10.1161/CIR.0000000000000558 29386200.

2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo J, Joseph L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report. JAMA. 2003;289(19):2560–71. doi: 10.1001/jama.289.19.2560 12748199

3. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H, et al. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. New England Journal of Medicine. 2001;345(12):861–9. doi: 10.1056/NEJMoa011161 11565518.

4. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382(9888):260–72. https://doi.org/10.1016/S0140-6736(13)60687-X.

5. Iadecola C, Davisson RL. Hypertension and Cerebrovascular Dysfunction. Cell metabolism. 2008;7(6):476–84. doi: 10.1016/j.cmet.2008.03.010 PMC2475602. 18522829

6. Kung HC, Xu J. Hypertension-related Mortality in the United States, 2000–2013. NCHS Data Brief. 2015;(193):1–8. 25932893.

7. Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, et al. Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines. New England Journal of Medicine. 2015;372(5):447–55. doi: 10.1056/NEJMsa1406751 25629742.

8. Friede A, Reid JA, Ory HW. CDC WONDER: a comprehensive on-line public health information system of the Centers for Disease Control and Prevention. American Journal of Public Health. 1993;83(9):1289–94. doi: 10.2105/ajph.83.9.1289 8395776

9. Brooks EG, Reed KD. Principles and Pitfalls: a Guide to Death Certification. Clinical medicine & research. 2015;13(2):74–84. doi: 10.3121/cmr.2015.1276 26185270.

10. Organization WH. International statistical classification of diseases and related health problems: World Health Organization; 2004.

11. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. 2001.

12. Jim MA, Arias E, Seneca DS, Hoopes MJ, Jim CC, Johnson NJ, et al. Racial misclassification of American Indians and Alaska Natives by Indian Health Service Contract Health Service Delivery Area. American journal of public health. 2014;104 Suppl 3(Suppl 3):S295–S302. Epub 06/. doi: 10.2105/AJPH.2014.301933 24754617.

13. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine. 2000;19(3):335–51. doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z 10649300

14. Lerman P. Fitting segmented regression models by grid search. Applied Statistics. 1980:77–84.

15. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. bmj. 2018;362:k2817. doi: 10.1136/bmj.k2817 30021785

16. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. European Respiratory Journal. 2008;32(4):962–9. doi: 10.1183/09031936.00012408 18579551

17. Hou L, Li Q, Jiang L, Qiu H, Geng C, Hong J-S, et al. Hypertension and Diagnosis of Parkinson's Disease: A Meta-Analysis of Cohort Studies. Frontiers in neurology. 2018;9:162–. doi: 10.3389/fneur.2018.00162 29615961.

18. Gangavati A, Hajjar I, Quach L, Jones RN, Kiely DK, Gagnon P, et al. Hypertension, Orthostatic Hypotension, and the Risk of Falls in a Community-Dwelling Elderly Population: The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston Study. Journal of the American Geriatrics Society. 2011;59(3):383–9. doi: 10.1111/j.1532-5415.2011.03317.x PMC3306056. 21391928

19. Montgomery DC. Introduction to statistical quality control: John Wiley & Sons; 2007.

20. Klein D, Nagel G, Kleiner A, Ulmer H, Rehberger B, Concin H, et al. Blood pressure and falls in community-dwelling people aged 60 years and older in the VHM&PP cohort. BMC Geriatrics. 2013;13(1):50. doi: 10.1186/1471-2318-13-50 23692779

21. Tinetti ME, Han L, Lee DSH, McAvay GJ, Peduzzi P, Gross CP, et al. Antihypertensive Medications and Serious Fall Injuries in a Nationally Representative Sample of Older Adults. JAMA internal medicine. 2014;174(4):588–95. doi: 10.1001/jamainternmed.2013.14764 PMC4136657. 24567036

22. Patel SA, Winkel M, Ali MK, Narayan K, Mehta NK. Cardiovascular mortality associated with 5 leading risk factors: National and state preventable fractions estimated from survey data. Annals of Internal Medicine. 2015;163(4):245–53. doi: 10.7326/M14-1753 26121190

23. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1736–88.

24. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990–2015. JAMA. 2017;317(2):165–82. doi: 10.1001/jama.2016.19043 28097354

25. Kirkland EB, Heincelman M, Bishu KG, Schumann SO, Schreiner A, Axon RN, et al. Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003–2014. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2018;7(11):e008731. doi: 10.1161/JAHA.118.008731 PMC6015342. 29848493

26. Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014;130(19):1692–9. Epub 2014/10/20. doi: 10.1161/CIRCULATIONAHA.114.010676 25332288.

27. German RR, Fink AK, Heron M, Stewart SL, Johnson CJ, Finch JL, et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiology. 2011;35(2):126–31. doi: 10.1016/j.canep.2010.09.005 20952269

28. Ma J, Ward EM, Siegel RL, Jemal A. Temporal trends in mortality in the united states, 1969–2013. JAMA. 2015;314(16):1731–9. doi: 10.1001/jama.2015.12319 26505597

29. Gelman A, Auerbach J. Age-aggregation bias in mortality trends. Proceedings of the National Academy of Sciences. 2016;113(7):E816–E7. doi: 10.1073/pnas.1523465113 26858421

30. Dorans KS, Mills KT, Liu Y, He J. Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline. Journal of the American Heart Association. 2018;7(11):e008888. doi: 10.1161/JAHA.118.008888 29858369.

31. Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. Journal of the American College of Cardiology. 2016;68(15):1609–17. doi: 10.1016/j.jacc.2016.07.745 27712772.

32. Dunford EK, Poti JM, Popkin BM. Emerging Disparities in Dietary Sodium Intake from Snacking in the US Population. Nutrients. 2017;9(6):610. doi: 10.3390/nu9060610 28629146.

33. Seeman T, Thomas D, Merkin SS, Moore K, Watson K, Karlamangla A. The Great Recession worsened blood pressure and blood glucose levels in American adults. Proceedings of the National Academy of Sciences. 2018. doi: 10.1073/pnas.1710502115 29531048


Článek vyšel v časopise

PLOS One


2020 Číslo 1